ClinicalTrials.Veeva

Menu

3 Year Follow up Study of the IDEA Population (IDEA2SCOLA)

H

Hôpital le Vinatier

Status

Completed

Conditions

Autism

Treatments

Behavioral: ESDM followed by treatment as usual

Study type

Interventional

Funder types

Other

Identifiers

NCT03924973
2017-A02446-47

Details and patient eligibility

About

The aim of this study is to assess the efficiency of early treatment for ASD children 5 years after initial treatment.

The early treatment implemented was 12 hours per week of ESDM versus treatment as usual during 2 years. This was done as an RCT, called IDEA. Children will now be included in IDEA-2 SCOLA, a three year follow up study.

Full description

180 children with ASD, younger than 3 years old, were included in the IDEA RCT. Children were allocated to the ESDM treatment group or the treatment as usual group. The aim of IDEA-2 is to follow-up this population for 3 years after the initial 2 years of intervention, that is, 5 years after initial inclusion to IDEA.

Investigators hypothesize that children who received ESDM 12 hours per week will have a significant decrease of autism symptoms and will have a better scholastic level 5 years after initial inclusion to IDEA.

Enrollment

93 patients

Sex

All

Ages

39 to 60 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Inclusion in the initial IDEA trail
  • Requiring less than 40 minutes travel to the assessment center

Exclusion criteria

  • Impossibility of coming in for assessment
  • Exclusion from IDEA

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

93 participants in 2 patient groups

Experimental group
Experimental group
Description:
Children below the age of 3 in this group received 2 years of ESDM intervention for 12 hours per week, and then treatment as usual for the 3 following years. What is called "treatment as usual" is what the community can usually offer. That is what the control group in IDEA received. In IDEA-2, both control and interventional group of IDEA will receive treatment as usual during 3 years. Treatment as usual comprises of different types of interventions, such as speech pathology therapy, occupational therapy and other types of therapy more or less specific to ASD in the community.
Treatment:
Behavioral: ESDM followed by treatment as usual
Control group
Other group
Description:
Children in this group received treatment as usual delivered in the community for the 2 years of IDEA. Participants will still receive treatment as usual delivered in the community during IDEA-2, in the 3 years following IDEA.
Treatment:
Behavioral: ESDM followed by treatment as usual

Trial contacts and locations

1

Loading...

Central trial contact

VIAL VERONIQUE; GEOFFRAY MARIE-MAUDE, PH

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems